Published in Ann Biomed Eng on February 01, 2005
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv Drug Deliv Rev (2009) 3.17
Nanomedicine--challenge and perspectives. Angew Chem Int Ed Engl (2009) 2.74
Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol (2015) 2.08
Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol (2010) 1.90
Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J Control Release (2013) 1.46
Mitotic trafficking of silicon microparticles. Nanoscale (2009) 1.35
Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. J Control Release (2010) 1.35
Cellular association and assembly of a multistage delivery system. Small (2010) 1.32
PRINT: a novel platform toward shape and size specific nanoparticle theranostics. Acc Chem Res (2011) 1.30
Enabling individualized therapy through nanotechnology. Pharmacol Res (2010) 1.28
Quantitative mechanics of endothelial phagocytosis of silicon microparticles. Cytometry A (2009) 1.16
Modeling particle shape-dependent dynamics in nanomedicine. J Nanosci Nanotechnol (2011) 1.14
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv (2010) 1.13
Nanovehicular intracellular delivery systems. J Pharm Sci (2008) 1.10
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) (2014) 1.07
Influence of Red Blood Cells on Nanoparticle Targeted Delivery in Microcirculation. Soft Matter (2011) 1.04
Near-infrared-resonant gold/gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small (2010) 1.03
The shape of things to come: importance of design in nanotechnology for drug delivery. Ther Deliv (2012) 1.03
An integrated approach for the rational design of nanovectors for biomedical imaging and therapy. Adv Genet (2010) 1.00
Dynamic factors controlling carrier anchoring on vascular cells. IUBMB Life (2011) 1.00
Flow chamber analysis of size effects in the adhesion of spherical particles. Int J Nanomedicine (2007) 0.99
Effect of spherical Au nanoparticles on nanofriction and wear reduction in dry and liquid environments. Beilstein J Nanotechnol (2012) 0.97
The margination propensity of spherical particles for vascular targeting in the microcirculation. J Nanobiotechnology (2008) 0.95
Design rules for nanomedical engineering: from physical virology to the applications of virus-based materials in medicine. J Biol Phys (2013) 0.94
Multistage Mesoporous Silicon-based Nanocarriers: Biocompatibility with Immune Cells and Controlled Degradation in Physiological Fluids. Controll Release Newsl (2008) 0.93
Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI. Proc Natl Acad Sci U S A (2008) 0.93
Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92
Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers. Cancer Lett (2012) 0.90
Blocking the adhesion cascade at the premetastatic niche for prevention of breast cancer metastasis. Mol Ther (2015) 0.88
Hematocrit and flow rate regulate the adhesion of platelets to von Willebrand factor. Biomicrofluidics (2013) 0.88
USNCTAM perspectives on mechanics in medicine. J R Soc Interface (2014) 0.83
Plasma protein corona modulates the vascular wall interaction of drug carriers in a material and donor specific manner. PLoS One (2014) 0.81
Particle margination and its implications on intravenous anticancer drug delivery. AAPS PharmSciTech (2014) 0.81
Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle Density. Angew Chem Int Ed Engl (2016) 0.80
Biomaterial Strategies for Immunomodulation. Annu Rev Biomed Eng (2015) 0.79
Computational simulations of magnetic particle capture in arterial flows. Ann Biomed Eng (2009) 0.79
Composites of Polymer Hydrogels and Nanoparticulate Systems for Biomedical and Pharmaceutical Applications. Nanomaterials (Basel) (2015) 0.78
Nanoencapsulation of insulin into zirconium phosphate for oral delivery applications. Biomacromolecules (2010) 0.78
Non-affinity factors modulating vascular targeting of nano- and microcarriers. Adv Drug Deliv Rev (2015) 0.78
Delivery of Polymeric Nanoparticles to Target Vascular Diseases. J Biomol Res Ther (2014) 0.77
Multiscale Modeling in the Clinic: Drug Design and Development. Ann Biomed Eng (2016) 0.77
Shape Control in Engineering of Polymeric Nanoparticles for Therapeutic Delivery. Biomater Sci (2015) 0.77
Strongly Accelerated Margination of Active Particles in Blood Flow. Biophys J (2016) 0.75
Capture Efficiency of Biocompatible Magnetic Nanoparticles in Arterial Flow: A Computer Simulation for Magnetic Drug Targeting. Nanoscale Res Lett (2015) 0.75
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat Nanotechnol (2017) 0.75
Direct intercalation of cisplatin into zirconium phosphate nanoplatelets for potential cancer nanotherapy. Nanoscale (2013) 0.75
Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies. Methodist Debakey Cardiovasc J (2013) 0.75
Direct Tracking of Particles and Quantification of Margination in Blood Flow. Biophys J (2016) 0.75
Influence of shear stress and size on viability of endothelial cells exposed to gold nanoparticles. J Nanopart Res (2017) 0.75
Sex and gender bias in anatomy and physical diagnosis text illustrations. JAMA (1994) 7.51
Nosocomial klebsiella infections: intestinal colonization as a reservoir. Ann Intern Med (1971) 6.55
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
Case-finding for depression in primary care: a randomized trial. Am J Med (1999) 4.46
Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO J (1999) 4.34
The limits and motivating potential of sensory stimuli as reinforcers for autistic children. J Appl Behav Anal (1981) 4.23
Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry (2008) 4.14
The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci U S A (1997) 3.75
Expression and function of CCR5 and CXCR4 on human Langerhans cells and macrophages: implications for HIV primary infection. Nat Med (1997) 3.55
Crystal structure of the yeast TFIIA/TBP/DNA complex. Science (1996) 3.45
Estimating the growth rate of slowly growing marine bacteria from RNA content. Appl Environ Microbiol (1993) 3.45
Switchable ferroelectric diode and photovoltaic effect in BiFeO3. Science (2009) 3.39
T-DNA insertional mutagenesis for functional genomics in rice. Plant J (2000) 3.25
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release (2009) 3.08
A Smad transcriptional corepressor. Cell (1999) 3.07
Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen. Clin Infect Dis (2011) 2.97
Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol (1986) 2.94
Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancy. Hum Genet (1983) 2.93
The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol (2000) 2.90
Dyspepsia is strongly associated with major depression and generalised anxiety disorder - a community study. Aliment Pharmacol Ther (2012) 2.80
The crystal structure of the peptide-binding fragment from the yeast Hsp40 protein Sis1. Structure (2000) 2.80
The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials (2006) 2.71
Paediatric hand fractures. J Hand Surg Eur Vol (2013) 2.65
Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta (1996) 2.64
A quasi-monoclonal mouse. Science (1996) 2.58
Characterization of somatostatin transactivating factor-1, a novel homeobox factor that stimulates somatostatin expression in pancreatic islet cells. Mol Endocrinol (1993) 2.57
Mixed human immunodeficiency virus (HIV) infection in an individual: demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis (1988) 2.56
Endothelial-leukocyte adhesion molecule 1 stimulates the adhesive activity of leukocyte integrin CR3 (CD11b/CD18, Mac-1, alpha m beta 2) on human neutrophils. J Exp Med (1991) 2.52
Knowledge and attitudes about depression among non-generalists and generalists. J Fam Pract (1997) 2.51
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Ohm's law survives to the atomic scale. Science (2012) 2.40
The mosaic organization of the apocytochrome b gene of Aspergillus nidulans revealed by DNA sequencing. Cell (1981) 2.38
Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia (2008) 2.37
Selection of antibiotic-resistant bacterial mutants: allelic diversity among fluoroquinolone-resistant mutations. J Infect Dis (2000) 2.35
Update on Hsp90 inhibitors in clinical trial. Curr Top Med Chem (2009) 2.34
Safety of sentinel node biopsy in pregnant patients with breast cancer. Ann Oncol (2004) 2.31
The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell (1992) 2.25
The mouse pink-eyed dilution gene: association with human Prader-Willi and Angelman syndromes. Science (1992) 2.23
Reaching our successors: the trend for early specialisation and the potential effect on recruitment to our speciality. J Plast Reconstr Aesthet Surg (2008) 2.21
CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med (1996) 2.21
Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity (1997) 2.18
The new definition of metabolic syndrome by the international diabetes federation is less likely to identify metabolically abnormal but non-obese individuals than the definition by the revised national cholesterol education program: the Korea NHANES study. Int J Obes (Lond) (2006) 2.11
The tomato Never-ripe locus regulates ethylene-inducible gene expression and is linked to a homolog of the Arabidopsis ETR1 gene. Plant Physiol (1995) 2.11
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Pathogenesis of the slow disease of the central nervous system associated with WM 1504 E virus. I. Relationship of strain susceptibility and replication to disease. Am J Pathol (1977) 2.08
Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice. J Exp Med (1981) 2.07
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect Immun (1994) 2.07
1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med (1999) 1.98
Cytokinins and auxins control the expression of a gene in Nicotiana plumbaginifolia cells by feedback regulation. Plant Cell (1992) 1.95
Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. J Am Acad Child Adolesc Psychiatry (1998) 1.94
Noninvasive measurement of forearm blood flow and oxygen consumption by near-infrared spectroscopy. J Appl Physiol (1985) (1994) 1.93
Immunologic competence of thoracic duct cells. I. Delayed hypersensitivity. J Exp Med (1966) 1.89
The impact of climate and traffic-related NO2 on the prevalence of asthma and allergic rhinitis in Italy. Clin Exp Allergy (2002) 1.87
Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax (2006) 1.86
Signals for retention of transmembrane proteins in the endoplasmic reticulum studied with CD4 truncation mutants. Proc Natl Acad Sci U S A (1991) 1.86
Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol (2001) 1.83
Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol (1995) 1.82
BAX protein expression and clinical outcome in epithelial ovarian cancer. J Clin Oncol (1998) 1.80
International application of a new probability algorithm for the diagnosis of coronary artery disease. Am J Cardiol (1989) 1.77
Molecular design of aquaporin-1 water channel as revealed by electron crystallography. Nat Struct Biol (1997) 1.77
DNA damage checkpoints and DNA replication controls in Saccharomyces cerevisiae. Mutat Res (2000) 1.76
Analysis of risk factors for the development of liver disease associated with cystic fibrosis. J Pediatr (1994) 1.76
A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group. Hepatology (1999) 1.75
Impact of micronutrient deficiencies on growth: the stunting syndrome. Ann Nutr Metab (2002) 1.73
Saccharomyces cerevisiae MSH2, a mispaired base recognition protein, also recognizes Holliday junctions in DNA. J Mol Biol (1997) 1.71
Structure of Semliki Forest virus core protein. Proteins (1997) 1.70
Proteins and cells on PEG immobilized silicon surfaces. Biomaterials (1998) 1.69
Renal homotransplantation in rats. I. Allogeneic recipients. J Exp Med (1967) 1.68
The receptor-mediated endocytosis of nonspherical particles. Biophys J (2008) 1.68
Isolation and characterization of toluene-sensitive mutants from the toluene-resistant bacterium Pseudomonas putida GM73. J Bacteriol (1998) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet (1998) 1.67
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Borderline personality disorder symptoms and severity of sexual abuse. Am J Psychiatry (1995) 1.65
Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J Virol (2001) 1.64
Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. J Biol Chem (1991) 1.62
leafy hull sterile1 is a homeotic mutation in a rice MADS box gene affecting rice flower development. Plant Cell (2000) 1.62
Grasping and dissecting instrument for hand-assisted laparoscopic surgery: development and early clinical experience. Surg Endosc (2002) 1.62
Pneumococcal septicemia in children with sickle cell anemia. Changing trend of survival. JAMA (1981) 1.62
Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol (1995) 1.62
Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum (1996) 1.61
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol (1992) 1.61
Characterization of the VHL tumor suppressor gene product: localization, complex formation, and the effect of natural inactivating mutations. Proc Natl Acad Sci U S A (1995) 1.61
The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. Biomaterials (2007) 1.60
Linkage disequilibrium between cystic fibrosis and linked DNA polymorphisms in Italian families: a collaborative study. Am J Hum Genet (1988) 1.60
Role of transforming growth factor-alpha in von Hippel--Lindau (VHL)(-/-) clear cell renal carcinoma cell proliferation: a possible mechanism coupling VHL tumor suppressor inactivation and tumorigenesis. Proc Natl Acad Sci U S A (2001) 1.59
The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc Natl Acad Sci U S A (1998) 1.59
Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles. Tissue Antigens (1995) 1.59
Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Leukemia (2006) 1.57
Immediate changes of collateral function after successful recanalization of chronic total coronary occlusions. Circulation (2000) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Determination of the functional affinity of IgG1 and IgG4 antibodies to tetanus toxoid by isotype-specific solid-phase assays. J Immunol Methods (1988) 1.56
Carfilzomib in multiple myeloma patients with renal impairment: pharmacokinetics and safety. Leukemia (2013) 1.56
Cutaneous aspergillosis and acquired immunodeficiency syndrome. Arch Dermatol (2000) 1.55
A self-supporting library service in a rural region: a new look at hospital consortia. Bull Med Libr Assoc (1982) 1.54
Homogeneous NMR spectra in inhomogeneous fields. Science (1996) 1.54
Alloxan diabetic neuropathy: electron microscopic studies. Neurology (1977) 1.53
Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol (1995) 1.53